Glück Conviction Score™ ⓘ
GNLX
GENELUX Corp
ⓘ
Eingeschränkte Aussagekraft — erst 62 % der Signal-Gewichte sind mit Daten unterlegt.
Effektiv: Neutral
Sehr niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
53,3
10 neu, 17 erhöht, -17173K $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 2.81 | +5.2 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 3.74 | -20.8 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 2.94 | EMA50: 2.88 | |
| MACD-Histogramm | Bärisch | 10 % | -0.021 | Bearisch | |
| RSI(14) | Neutral | 10 % | 52.4 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 41.7 | Neutral | |
| ADX(14)+DI | Bullisch | 10 % | 25.3 | +DI: 21.0 / −DI: 14.7 | |
| Z-Score(60) | Neutral | 5 % | 0.93 | In Range | |
| 52W-Position | Bärisch | 5 % | 11.1 % | Hoch 8.24 / Tief 2.30 | |
| Bollinger(20,2σ) | Neutral | 5 % | 52.2 % | Upper 3.10 / Mid 2.95 / Lower 2.81 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.0102 | R²=0.67 / annualisiert +93.3 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | Smalling Ralph | Officer, Head of Regulatory | Open Market Sale | -192 | 2,93 | -562,56 | -5,6% | |
| 2026-06-01 | Thomas John | Director | Open Market Sale | -10.000 | 2,98 | -29.801,00 | -295,6% | |
| 2026-05-11 | Smalling Ralph | Officer, Head of Regulatory | Open Market Sale | -270 | 2,98 | -804,49 | -8,0% | |
| 2026-05-11 | Zindrick Thomas | Officer, President and CEO | Open Market Sale | -2.798 | 2,94 | -8.225,56 | -81,6% | |
| 2026-05-11 | Yu Yong | Officer, Chief Scientific Officer | Open Market Sale | -605 | 2,97 | -1.798,42 | -17,8% | |
| 2026-05-11 | Cappello Joseph | Officer, Chief Technical Officer | Open Market Sale | -605 | 2,97 | -1.799,39 | -17,8% | |
| 2026-03-25 | Smalling Ralph | Officer, Head of Regulatory | Open Market Sale | -240 | 2,51 | -602,40 | -6,0% | |
| 2026-03-24 | Yu Yong | Officer, SVP, Clinical Development | Open Market Sale | -906 | 2,42 | -2.192,52 | -21,7% | |
| 2026-03-24 | Zindrick Thomas | Officer, President and CEO | Open Market Sale | -3.582 | 2,42 | -8.668,44 | -86,0% | |
| 2026-03-24 | Cappello Joseph | Officer, Chief Technical Officer | Open Market Sale | -906 | 2,42 | -2.192,52 | -21,7% | |
| 2026-03-24 | Smalling Ralph | Officer, Head of Regulatory | Open Market Sale | -345 | 2,42 | -834,90 | -8,3% | |
| 2026-03-02 | Thomas John | Director | Open Market Sale | -10.000 | 2,90 | -28.957,00 | -287,2% | |
| 2025-12-05 | Smalling Ralph | Officer, Head of Regulatory | Open Market Sale | -165 | 4,69 | -773,85 | -7,7% | |
| 2025-12-01 | Thomas John | Director | Open Market Sale | -10.000 | 5,00 | -50.008,00 | -496,0% | |
| 2025-11-17 | Yu Yong | Officer, SVP, Clinical Development | Open Market Sale | -973 | 5,37 | -5.224,43 | -51,8% | |
| 2025-11-17 | Smalling Ralph | Officer, Head of Regulatory | Open Market Sale | -343 | 5,37 | -1.841,70 | -18,3% | |
| 2025-11-17 | Zindrick Thomas | Officer, President and CEO | Open Market Sale | -4.509 | 5,37 | -24.210,62 | -240,2% | |
| 2025-11-17 | Cappello Joseph | Officer, Chief Technical Officer | Open Market Sale | -973 | 5,37 | -5.224,43 | -51,8% | |
| 2025-09-03 | Smalling Ralph | Officer, Head of Regulatory | Open Market Sale | -580 | 3,36 | -1.948,22 | -19,3% | |
| 2025-08-21 | Smalling Ralph | Officer, Head of Regulatory | Open Market Sale | -1.244 | 3,36 | -4.176,61 | -41,4% | |
| 2025-08-21 | Zindrick Thomas | Officer, President and CEO | Open Market Sale | -12.673 | 3,33 | -42.159,27 | -418,2% | |
| 2025-08-21 | Yu Yong | Officer, SVP, Clinical Development | Open Market Sale | -3.219 | 3,36 | -10.807,47 | -107,2% | |
| 2025-08-21 | Cappello Joseph | Officer, Chief Technical Officer | Open Market Sale | -1.463 | 3,36 | -4.911,88 | -48,7% | |
| 2025-08-21 | Cappello Joseph | Officer, Chief Technical Officer | Open Market Sale | -1.270 | 3,33 | -4.224,91 | -41,9% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 1.551.449 | 0 | 1.551.449 | 6.764.318 | Neu | +100,0% | |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 2.117.183 | 1.932.711 | 184.472 | 5.906.941 | Aufgestockt | +9,5% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.695.480 | 0 | 1.695.480 | 4.103.062 | Neu | +100,0% | |
| Bleichroeder LP | 1.380.666 | 714.000 | 666.666 | 3.341.212 | Aufgestockt | +93,4% | |
| Alyeska Investment Group, L.P. | 285.000 | 0 | 285.000 | 1.242.600 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 453.761 | 381.407 | 72.354 | 1.098.677 | Aufgestockt | +19,0% | |
| BlackRock, Inc. | 405.872 | 385.308 | 20.564 | 982.210 | Aufgestockt | +5,3% | |
| Global Retirement Partners, LLC | 217.092 | 0 | 217.092 | 946.520 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 323.865 | 336.021 | -12.156 | 783.753 | Reduziert | -3,6% | |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 280.904 | 303.314 | -22.410 | 679.788 | Reduziert | -7,4% | |
| MARSHALL WACE, LLP | 139.148 | 0 | 139.148 | 606.685 | Neu | +100,0% | |
| CM Management, LLC | 250.000 | 0 | 250.000 | 605.000 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 104.399 | 0 | 104.399 | 455.180 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 92.795 | 0 | 92.795 | 404.586 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 164.456 | 142.838 | 21.618 | 397.984 | Aufgestockt | +15,1% | |
| Provident Wealth Management, LLC | 155.670 | 155.670 | 0 | 376.721 | Unverändert | 0,0% | |
| STATE STREET CORP | 145.850 | 145.850 | 0 | 352.957 | Unverändert | 0,0% | |
| LPL Financial LLC | 139.041 | 134.357 | 4.684 | 336.479 | Aufgestockt | +3,5% | |
| UBS Group AG | 122.579 | 47.360 | 75.219 | 296.641 | Aufgestockt | +158,8% | |
| OSAIC HOLDINGS, INC. | 119.008 | 109.987 | 9.021 | 287.998 | Aufgestockt | +8,2% | |
| LifeSteps Financial, Inc. | 118.862 | 118.075 | 787 | 287.646 | Aufgestockt | +0,7% | |
| ExodusPoint Capital Management, LP | 54.633 | 0 | 54.633 | 238.200 | Neu | +100,0% | |
| MORGAN STANLEY | 88.048 | 92.189 | -4.141 | 213.076 | Reduziert | -4,5% | |
| AMG National Trust Bank | 75.351 | 75.351 | 0 | 182.349 | Unverändert | 0,0% | |
| Point72 Asset Management, L.P. | 39.560 | 0 | 39.560 | 172.482 | Neu | +100,0% | |
| Falcon Wealth Planning | 63.185 | 63.185 | 0 | 152.908 | Unverändert | 0,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 61.980 | 271.323 | -209.343 | 149.992 | Reduziert | -77,2% | |
| SteelPeak Wealth, LLC | 60.895 | 10.895 | 50.000 | 147.366 | Aufgestockt | +458,9% | |
| 683 Capital Management, LLC | 60.000 | 131.084 | -71.084 | 145.200 | Reduziert | -54,2% | |
| Creative Planning | 45.572 | 43.808 | 1.764 | 110.284 | Aufgestockt | +4,0% | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 41.000 | 37.000 | 4.000 | 105.370 | Aufgestockt | +10,8% | |
| KWB Wealth | 23.327 | 23.327 | 0 | 101.706 | Unverändert | 0,0% | |
| Richard Young Associates, Ltd. | 40.959 | 40.959 | 0 | 99.121 | Unverändert | 0,0% | |
| Lighthouse Investment Partners, LLC | 22.560 | 0 | 22.560 | 98.362 | Neu | +100,0% | |
| BALYASNY ASSET MANAGEMENT L.P. | 21.465 | 0 | 21.465 | 93.587 | Neu | +100,0% | |
| Hudson Bay Capital Management LP | 37.735 | 37.735 | 0 | 91.319 | Unverändert | 0,0% | |
| CITADEL ADVISORS LLC | 19.415 | 0 | 19.415 | 84.649 | Neu | +100,0% | |
| WAYSTONE ADVISORS LLC | 33.332 | 33.332 | 0 | 80.663 | Unverändert | 0,0% | |
| BARCLAYS PLC | 32.756 | 82.604 | -49.848 | 79.269 | Reduziert | -60,3% | |
| GOLDMAN SACHS GROUP INC | 32.610 | 183.807 | -151.197 | 78.916 | Reduziert | -82,3% | |
| One Capital Management, LLC | 30.883 | 30.883 | 0 | 74.736 | Unverändert | 0,0% | |
| RAYMOND JAMES FINANCIAL INC | 30.758 | 30.758 | 0 | 74.435 | Unverändert | 0,0% | |
| GROUP ONE TRADING LLC | 29.800 | 24.555 | 5.245 | 72.116 | Aufgestockt | +21,4% | |
| Mariner, LLC | 27.866 | 0 | 27.866 | 67.436 | Neu | +100,0% | |
| CITIGROUP INC | 14.945 | 0 | 14.945 | 65.160 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 25.000 | 25.000 | 0 | 60.500 | Unverändert | 0,0% | |
| XTX Topco Ltd | 22.935 | 51.023 | -28.088 | 55.503 | Reduziert | -55,0% | |
| Catalyst Funds Management Pty Ltd | 21.824 | 0 | 21.824 | 52.814 | Neu | +100,0% | |
| D.A. DAVIDSON & CO. | 21.779 | 21.779 | 0 | 52.705 | Unverändert | 0,0% | |
| Squarepoint Ops LLC | 11.866 | 0 | 11.866 | 51.736 | Neu | +100,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| WOODWARD DIVERSIFIED CAPITAL, LLC | 2.117.183 | 1.932.711 | +9,5% | 5.906.941 | 26,00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.695.480 | 0 | +100,0% | 4.103.062 | 18,06 |
| Bleichroeder LP | 1.380.666 | 714.000 | +93,4% | 3.341.212 | 14,70 |
| GEODE CAPITAL MANAGEMENT, LLC | 453.761 | 381.407 | +19,0% | 1.098.677 | 4,84 |
| BlackRock, Inc. | 405.872 | 385.308 | +5,3% | 982.210 | 4,32 |
| BANK OF AMERICA CORP /DE/ | 323.865 | 336.021 | -3,6% | 783.753 | 3,45 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 280.904 | 303.314 | -7,4% | 679.788 | 2,99 |
| CM Management, LLC | 250.000 | 0 | +100,0% | 605.000 | 2,66 |
| NORTHERN TRUST CORP | 164.456 | 142.838 | +15,1% | 397.984 | 1,75 |
| Provident Wealth Management, LLC | 155.670 | 155.670 | 0,0% | 376.721 | 1,66 |
| STATE STREET CORP | 145.850 | 145.850 | 0,0% | 352.957 | 1,55 |
| LPL Financial LLC | 139.041 | 134.357 | +3,5% | 336.479 | 1,48 |
| UBS Group AG | 122.579 | 47.360 | +158,8% | 296.641 | 1,31 |
| OSAIC HOLDINGS, INC. | 119.008 | 109.987 | +8,2% | 287.998 | 1,27 |
| LifeSteps Financial, Inc. | 118.862 | 118.075 | +0,7% | 287.646 | 1,27 |
| MORGAN STANLEY | 88.048 | 92.189 | -4,5% | 213.076 | 0,94 |
| AMG National Trust Bank | 75.351 | 75.351 | 0,0% | 182.349 | 0,80 |
| Falcon Wealth Planning | 63.185 | 63.185 | 0,0% | 152.908 | 0,67 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 61.980 | 271.323 | -77,2% | 149.992 | 0,66 |
| SteelPeak Wealth, LLC | 60.895 | 10.895 | +458,9% | 147.366 | 0,65 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 72 | 11,0 | 27 |
| 31.12.2025 | ✓ | 77 | 9,5 | 41 |
| 30.09.2025 | ✓ | 59 | 7,9 | 33 |
| 30.06.2025 | ✓ | 62 | 7,5 | 21 |
| 31.03.2025 | ✓ | 74 | 7,6 | 20 |
| 31.12.2024 | ✓ | 57 | 5,0 | 12 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| 683 Capital Management, LLC | 131.084 | 571.526 |
| MILLENNIUM MANAGEMENT LLC | 104.399 | 455.180 |
| BARCLAYS PLC | 82.604 | 360.153 |
| JANE STREET GROUP, LLC | 71.741 | 312.791 |
| OMERS ADMINISTRATION Corp | 54.800 | 238.928 |
| ExodusPoint Capital Management, LP | 54.633 | 238.200 |
| XTX Topco Ltd | 51.023 | 222.460 |
| Richard Young Associates, Ltd. | 40.959 | 178.581 |
| Point72 Asset Management, L.P. | 39.560 | 172.482 |
| Hudson Bay Capital Management LP | 37.735 | 164.525 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 271.323 | 218.940 | +418.0 % | 1.182.968 |
| GOLDMAN SACHS GROUP INC | 183.807 | 150.463 | +451.2 % | 801.398 |
| VANGUARD GROUP INC | 1.551.449 | 132.068 | +9.3 % | 6.764.318 |
| MARSHALL WACE, LLP | 139.148 | 105.402 | +312.3 % | 606.685 |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 1.932.711 | 88.612 | +4.8 % | 8.426.620 |
| Qube Research & Technologies Ltd | 92.795 | 55.571 | +149.3 % | 404.586 |
| Falcon Wealth Planning | 63.185 | 41.185 | +187.2 % | 275.487 |
| MORGAN STANLEY | 92.189 | 31.545 | +52.0 % | 401.944 |
| GEODE CAPITAL MANAGEMENT, LLC | 381.407 | 27.567 | +7.8 % | 1.663.923 |
| STATE STREET CORP | 145.850 | 27.200 | +22.9 % | 635.906 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 23.100 | -39.800 | -63.3 % | 100.716 |
| CITADEL ADVISORS LLC | 19.415 | -35.128 | -64.4 % | 84.649 |
| SIMPLEX TRADING, LLC | 1.514 | -17.786 | -92.2 % | 6.601 |
| Global Retirement Partners, LLC | 217.092 | -11.584 | -5.1 % | 946.520 |
| MAI Capital Management | 25.878 | -6.115 | -19.1 % | 112.829 |
| 5T Wealth, LLC | 18.001 | -6.100 | -25.3 % | 78.484 |
| ROYAL BANK OF CANADA | 46 | -6.098 | -99.3 % | 0 |
| JPMORGAN CHASE & CO | 26 | -2.920 | -99.1 % | 113 |
| OSAIC HOLDINGS, INC. | 109.987 | -2.479 | -2.2 % | 479.543 |
| Creative Planning | 43.808 | -2.300 | -5.0 % | 191.003 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 17.02.2026 | Aladar Szalay | Passiv (13G/A) | 8,20 % | 3.134.286 | -0,20 pp | |
| 14.11.2025 | Steven Boyd | Passiv (13G) | 9,99 % | 4.223.277 | Neu | |
| 14.11.2025 | Armistice Capital, LLC | Passiv (13G) | 9,99 % | 4.223.277 | Neu | |
| 25.07.2025 | Aladar Szalay | Passiv (13G/A) | 8,40 % | 3.171.508 | -1,50 pp | |
| 25.10.2024 | Highbridge Capital Management, LLC | Passiv (13G) | 6,80 % | 2.500.000 | Neu | |
| 22.10.2024 | Aladar Szalay | Passiv (13G/A) | 9,90 % | 3.413.581 | Neu | |
| 02.02.2024 | Aladar Szalay | Passiv (13G) | 15,70 % | 4.185.305 | Neu | |
| 20.06.2023 | Billy James Parrott | Passiv (13G) | 8,70 % | 2.325.547 | Neu |
Stammdaten
Genelux Corporation ist ein klinisches Biopharmaka-Unternehmen, das sich auf die Entwicklung von Onkolytischen-Virus-Immuntherapien der nächsten Generation für Patienten mit aggressiven und/oder schwer zu behandelnden soliden Tumoren konzentriert. Das führende Produktkandidat ist Olvi-Vec, ein firmeneigener modifizierter Vaccinia-Virus-Stamm zur Behandlung von Eierstockkrebs und nicht-kleinzelligem Lungenkrebs. Das Unternehmen entwickelt auch V2ACT-Immuntherapie zur Behandlung von Bauchspeicheldrüsenkrebs sowie V-VET1 zur Behandlung von hämatologischen und soliden Krebserkrankungen. Das Unternehmen wurde 2001 gegründet und hat seinen Sitz in Westlake Village, Kalifornien.
Unternehmen & Branche
| Name | GENELUX Corp |
|---|---|
| Ticker | GNLX |
| CIK | 0001231457 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 36870H103 |
|---|---|
| ISIN | US36870H1032 |
| Typ | Common Stock |
| Marktkapitalisierung | 108,1 Mio. USD |
| Beta | 0,47 |
Bewertung
| KBV (P/B) | 9,37 |
|---|---|
| KUV (P/S) | 13.515,56 |
| FCF-Rendite | -24,4 % |
Qualität & Bilanz
| Operative Marge | -415.175,0 % vs. -27,2 % (2022) ▼ |
|---|---|
| Nettomarge | -401.812,5 % vs. -47,0 % (2022) ▼ |
| ROIC | -243,0 % |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2022. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|
| Bewertung | |||||
| KBV (P/B) | – | 19,27 | 3,12 | 14,40 | |
| KUV (P/S) | – | 2.207,73 | 10.244,80 | 20.785,83 | |
| FCF-Rendite | – | -5,7 % | -26,4 % | -15,9 % | |
| Qualität & Bilanz | |||||
| Operative Marge | -27,2 % | -14.214,7 % | -396.200,0 % | -415.175,0 % | |
| Nettomarge | -47,0 % | -16.645,3 % | -373.362,5 % | -401.812,5 % | |
| ROIC | – | -123,6 % | -106,1 % | -243,0 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -8.928.000 | -0,20 | 32.372.000 | 22.921.000 | |
| 2025-12-31 | 10-K | 8.000 | -32.145.000 | -0,86 | 19.027.000 | 11.544.000 |
| 2025-09-30 | 10-Q | -7.950.000 | -0,21 | 24.987.000 | 18.591.000 | |
| 2025-06-30 | 10-Q | -7.456.000 | -0,20 | 32.247.000 | 23.898.000 | |
| 2025-03-31 | 10-Q | 8.000 | -7.492.000 | -0,21 | 38.985.000 | 29.846.000 |
| 2024-12-31 | 10-K | 8.000 | -29.869.000 | -0,95 | 34.716.000 | 26.274.000 |
| 2024-09-30 | 10-Q | -6.467.000 | -0,19 | 40.270.000 | 33.091.000 | |
| 2024-06-30 | 10-Q | -6.576.000 | -0,22 | 45.179.000 | 37.669.000 | |
| 2024-03-31 | 10-Q | 8.000 | -7.850.000 | -0,29 | 24.676.000 | 15.084.000 |
| 2023-12-31 | 10-K | 170.000 | -28.297.000 | -1,16 | 27.893.000 | 19.473.000 |
| 2023-09-30 | 10-Q | -5.345.000 | -0,20 | 34.072.000 | 24.028.000 | |
| 2023-06-30 | 10-Q | -5.821.000 | -0,23 | 31.363.000 | 22.256.000 | |
| 2023-03-31 | 10-Q | 170.000 | -10.364.000 | -0,53 | 14.616.000 | 2.691.000 |
| 2022-12-31 | 10-K | 11.068.000 | -5.207.000 | -0,57 | 5.531.000 | -35.783.000 |
| 2022-09-30 | 10-Q | 11.000.000 | 4.909.000 | 0,49 | -32.331.000 | |
| 2022-06-30 | 10-Q | -2.820.000 | 0,31 | -39.063.000 | ||
| 2022-03-31 | 10-Q | -3.801.000 | -36.540.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|
| Operating And Reportable Segments | 8.000 | 8.000 | 170.000 | 100,0 % | 0,0% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | – | -0,20 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | – | -0,21 |
| Q2 2025 | 30.06.2025 | 05.11.2025 | – | -0,20 |
| Q1 2025 | 31.03.2025 | 07.05.2026 | – | -0,21 |
| Q3 2024 | 30.09.2024 | 05.11.2025 | – | -0,19 |
| Q2 2024 | 30.06.2024 | 05.11.2025 | – | -0,22 |
| Q1 2024 | 31.03.2024 | 05.11.2025 | 8.000 USD | -0,29 |
| Q3 2023 | 30.09.2023 | 14.11.2024 | – | -0,20 |
| Q2 2023 | 30.06.2023 | 14.08.2024 | – | -0,23 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | 31.03.2026 | 37 Tage | SEC » |
| 19.03.2026 | 10-K | 31.12.2025 | 78 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 06.05.2025 | 10-Q | 31.03.2025 | 36 Tage | SEC » |
| 29.04.2025 | 10-K/A | 31.12.2024 | 119 Tage | SEC » |
| 28.03.2025 | 10-K | 31.12.2024 | 87 Tage | SEC » |
| 14.11.2024 | 10-Q | 30.09.2024 | 45 Tage | SEC » |
| 14.08.2024 | 10-Q | 30.06.2024 | 45 Tage | SEC » |
| 09.05.2024 | 10-Q | 31.03.2024 | 39 Tage | SEC » |
| 29.03.2024 | 10-K | 31.12.2023 | 89 Tage | SEC » |
| 14.11.2023 | 10-Q | 30.09.2023 | 45 Tage | SEC » |
| 14.08.2023 | 10-Q | 30.06.2023 | 45 Tage | SEC » |
| 15.05.2023 | 10-Q | 31.03.2023 | 45 Tage | SEC » |
| 01.05.2023 | 10-K/A | 31.12.2022 | 121 Tage | SEC » |
| 29.03.2023 | 10-K | 31.12.2022 | 88 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 03.09.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 03.10.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory… |
| 24.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory… |
| 14.09.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 28.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 14.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Transfer of Listing. Reference is made to Item 5.02 below. Due to the vacancy resulting from Mr. Woodward’s… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-11 | 2.338 | 3,11 | 7.271 |
| 2026-05-06 | 193 | 2,77 | 535 |
| 2026-05-05 | 3.237 | 2,85 | 9.225 |
| 2026-04-30 | 478 | 2,50 | 1.195 |
| 2026-04-29 | 6 | 2,53 | 15 |
| 2026-04-21 | 5.886 | 2,65 | 15.598 |
| 2026-04-20 | 294 | 2,79 | 820 |
| 2026-04-16 | 25.449 | 2,84 | 72.275 |
| 2026-04-07 | 1.061 | 2,73 | 2.897 |
| 2026-04-02 | 330 | 2,56 | 845 |
| 2026-03-27 | 1.034 | 2,63 | 2.719 |
| 2026-03-25 | 4.533 | 2,42 | 10.970 |
| 2026-03-24 | 169 | 2,48 | 419 |
| 2026-03-20 | 3.339 | 2,54 | 8.481 |
| 2026-03-18 | 3.500 | 2,62 | 9.170 |
| 2026-03-16 | 6.572 | 2,60 | 17.087 |
| 2026-03-12 | 6.675 | 2,78 | 18.557 |
| 2026-02-17 | 1.242 | 2,61 | 3.242 |
| 2026-01-27 | 4 | 2,85 | 11 |
| 2026-01-21 | 4.555 | 2,73 | 12.435 |
| 2026-01-20 | 10.031 | 2,74 | 27.485 |
| 2026-01-15 | 906 | 2,61 | 2.365 |
| 2026-01-12 | 13.831 | 2,80 | 38.727 |
| 2026-01-09 | 2.005 | 2,72 | 5.454 |
| 2026-01-05 | 1.241 | 4,55 | 5.647 |
| 2025-12-31 | 1.403 | 4,34 | 6.089 |
| 2025-12-30 | 2.049 | 4,38 | 8.975 |
| 2025-12-29 | 1.449 | 4,37 | 6.332 |
| 2025-12-22 | 25 | 4,20 | 105 |
| 2025-12-18 | 2.036 | 4,15 | 8.449 |
| 2025-12-17 | 877 | 4,10 | 3.596 |
| 2025-12-15 | 1.149 | 4,31 | 4.952 |